1 results for "Massimo Statuto"

A comparative assessment of radiochemical purity and yield of [18F]PSMA-1007 production using two different automated synthesis platforms: a head-to-head comparison

Michela Cossandi; Massimo Statuto; Elena Migliorati et al.

EJNMMI Radiopharmacy and Chemistry, Vol. 11 No. 1 · 2026 · English · DOAJ Scopus

Abstract Background Glutamate carboxypeptidase II (GCPII), also known as prostate-specific membrane antigen (PSMA) is overexpressed in 90–100% of prostate cancer cells. The radiopharmaceutical [18F]PSMA-1007, recognised as a PET tracer for prostate cancer imaging, is based on PSMA inhibitor…